Specialized Cocktail for Cerebral Edema in Large Ischemic Stroke

Large ischemic stroke is a serious condition that can lead to significant brain swelling and pressure inside the skull, often resulting in poor recovery. Current treatments sometimes fail to prevent this swelling, even when procedures to restore blood flow are successful. This study aims to test a new combination of medicines, referred to as PPA, which might reduce brain swelling by balancing certain chemicals in the brain and improving fluid drainage. The study focuses on patients who have experienced a large stroke affecting the middle cerebral artery and are not undergoing surgery to relieve pressure. The hope is to find a better way to manage swelling and improve recovery for these patients. Participants in the study will be split into two groups: one will receive the PPA treatment while the other will receive standard care. The PPA treatment involves a specific regimen of drugs administered over five days, with careful monitoring of blood pressure. The main focus is to see if the new treatment reduces brain swelling within a week, checked through imaging. Researchers will also look at how patients are doing three months later in terms of their overall recovery. Safety is a priority, and any side effects, such as low blood pressure, will be monitored. Patients or their representatives will provide consent to join the study, ensuring ethical standards are met.